Literature DB >> 23747546

Expression of a truncated hepatitis E virus capsid protein in the protozoan organism Leishmania tarentolae and its application in a serological assay.

C Baechlein1, D Meemken, G Pezzoni, C Engemann, B Grummer.   

Abstract

Zoonotic infections with hepatitis E virus (HEV) genotype 3 are presumably transmitted via contaminated pig meat products, which raises the necessity for enhanced serological surveillance of pig herds. The aim of the study was to set up a novel protein expression system to overcome the well-known problems in (HEV-) protein expression using the standard Escherichia coli tools such as inclusion body formation and loss of protein conformation. A recombinant strain of the protozoan organism Leishmania tarentolae (L. tarentolae) was therefore established. A fragment of HEV ORF2 coding for a truncated capsid protein of a porcine HEV strain was cloned and parts of the plasmid DNA were introduced into the Leishmania genome, resulting in stably transformed cells. Via a C-terminal His-tag the recombinant HEVΔORF2 protein could be purified and concentrated directly from the medium, resulting in a total protein amount of approximately 1.4 mg/l Leishmania culture. The recombinant protein was coated on ELISA plates and was proven to be highly reactive and well-suited to be applied in a serological assay. By investigating 144 porcine sera, the in-house assay detected specific antibodies in 43.1% of the samples and demonstrated a higher sensitivity than a commercially available antibody test. Taken together, it was shown that L. tarentolae exhibits a remarkable alternative expression strategy for viral antigens with considerable advantages of a eukaryotic protein expression host.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antigen expression; Leishmania tarentolae; Pig; Serology; Zoonosis

Mesh:

Substances:

Year:  2013        PMID: 23747546     DOI: 10.1016/j.jviromet.2013.05.018

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

Review 1.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

2.  Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex.

Authors:  Katarzyna Grzyb; Anna Czarnota; Agnieszka Brzozowska; Anna Cieślik; Łukasz Rąbalski; Jolanta Tyborowska; Krystyna Bieńkowska-Szewczyk
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

3.  Detection of Serum Antibodies to Hepatitis E Virus Based on HEV Genotype 3 ORF2 Capsid Protein Expressed in Nicotiana benthamiana.

Authors:  Milena Mazalovska; Nikola Varadinov; Tsvetoslav Koynarski; Ivan Minkov; Pavel Teoharov; George P Lomonossoff; Gergana Zahmanova
Journal:  Ann Lab Med       Date:  2017-07       Impact factor: 3.464

4.  Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.

Authors:  Kerstin Fischer; Sandra Diederich; Greg Smith; Sven Reiche; Vinicius Pinho Dos Reis; Eileen Stroh; Martin H Groschup; Hana M Weingartl; Anne Balkema-Buschmann
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

5.  Epidemic Preparedness-Leishmania tarentolae as an Easy-to-Handle Tool to Produce Antigens for Viral Diagnosis: Application to COVID-19.

Authors:  Ilaria Varotto-Boccazzi; Alessandro Manenti; Francesca Dapporto; Louise J Gourlay; Beatrice Bisaglia; Paolo Gabrieli; Federico Forneris; Silvia Faravelli; Valentina Bollati; Diego Rubolini; Gianvincenzo Zuccotti; Emanuele Montomoli; Sara Epis; Claudio Bandi
Journal:  Front Microbiol       Date:  2021-12-13       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.